Menu
Recruiting NCT05911893

the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children

No phase Interventional Malnutrition, Child Malnourishment Nutritional Deficiency Undernutrition

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: high caloric oral nutritional supplements, nutritional education, dietary guidance.
Who it may be relevant to
Registry conditions: Malnutrition, Child, Malnourishment, Nutritional Deficiency, Undernutrition. Basic parameters: 1 year — 3 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this clinical trial is to investigate the effect of high caloric oral nutritional supplements on body proportion, weight, linear growth pattern, neuropsychological development level and related health aspects (gut health, immune function, quality of life, etc.) in participants aged 1 to 3 years who are malnourished (underweight and wasting),as well as to evaluate the safety of applying high caloric oral nutritional supplements. Participants will receive nutritional education and daily high caloric oral nutritional supplements(experimental group),or will receive nutritional education and dietary instruction(control group).This study may provide data to support the development of clinical intervention strategies for malnourished Chinese children.

Detailed description

Background:Growth and development is an important indicator of children's health and nutritional status, and nutrition is the most important material basis for growth and development. The prevention and treatment of malnutrition in children can be achieved by choosing whole nutritional formulas for special medical purposes as oral nutritional supplements (ONS), which has been confirmed by some overseas clinical studies to promote the growth benefit of malnourished children, but no multicenter clinical study has been conducted in China on the effect of ONS on the improvement of growth and development of malnourished Chinese children.

Objective and significance: To investigate the effects of high caloric ONS on body proportion, weight, linear growth pattern, neuropsychological development level and related health aspects (gut health, immune function, quality of life, etc.) in children, as well as to evaluate the safety of applying high caloric ONS, and to provide data to support the development of clinical intervention strategies for malnourished Chinese children.

Research design:A multicenter, randomized, controlled clinical trial design method is used to randomize children who meet the inclusion criteria into the experimental and control groups using a competitive entry method. The test group is given nutritional education and high caloric ONS (which can supplement 30% of the energy requirement), while the control group is given nutritional education and dietary instruction.Participants are followed up at 0, 1,2, 3, 6, and 12 months of enrollment. The investigators will collect dietary diaries, physical indicators, developmental quotient scores, quality of life measures, gut health, infectious disease-related questionnaires and safety indicators (blood biochemical indicators, urine routine) from children in both groups to comprehensively assess the effect of high caloric ONS intervention on physical growth, neuropsychological development levels and related aspects (gut health, immune function, quality of life, etc.) of malnourished children, as well as to conduct safety analyses.

Sample size:According to similar studies to date, a total of 200 people are recommended for this study.

Statistical analysis: Statistical analysis is performed using SAS 9.4. For continuous variables (height, weight, BMI-Z score, DQ score, etc.), statistical descriptions are performed using mean and standard deviation (conforming to normal distribution) or median and interquartile range (IQR); for categorical variables, statistical descriptions are performed using frequency and percentage; for the main efficacy indicators, mixed-effects models are used for efficacy evaluation indicators according to the principle of adjusted intentionality analysis (mITT). For the safety evaluation, the number, frequency and incidence of adverse events and reactions are calculated, and the positive abnormal changes of laboratory biochemical indexes such as blood routine, urine routine, liver and kidney function are counted. p value \< 0.05 is considered statistically significant.

Ethical matters and data protection: The guardians of the children participating in the study will sign an informed consent form. This study is approved by the local ethics committee. Patients' names will be abbreviated and study data will be assigned a code which will then be provided to the investigator. Parental authorization for patient health information will remain in effect until the study is completed. After that, private information will be removed from the study records by the researcher.

Interventions

  • Dietary supplement high caloric oral nutritional supplements
    High caloric oral nutritional supplements (which can supplement 30% of the energy requirement) is given daily, and the recommended amount of energy and protein is referred to the 2013 Chinese Dietary Nutrient Reference Intake Table. At 6 months of enrollment, participants will be asked to evaluate whether to continue feeding according to the experimental group protocol or to stop to ensure proper nutritional intake.
  • Behavioral nutritional education
    After enrollment,health education information is pushed approximately every 4 weeks through the WeChat platform or/and short text messages to parents.
  • Behavioral dietary guidance
    At follow-up visits at 0, 1, 2, 3, 6,and 12 months after enrollment, a professionally trained pediatrician give the participant's guardian dietary instructions appropriate to the age stage and physical condition of the child. Each session lasts approximately 10 minutes.

Primary outcome measures

  • BMI for Age Z-score(BAZ) [Time frame: at 6 months of enrollment]
Secondary outcome measures (12)
  • Dietary Diary [Time frame: at 0, 1, 2, 3, 6 and 12 months of enrollment]
  • BMI for Age Z-score(BAZ) [Time frame: at 0, 1, 2, 3 and 12 months of enrollment]
  • Weight for Age Z-score(WAZ) [Time frame: at 0, 1, 2, 3, 6 and 12 months of enrollment]
  • Height for Age Z-score(HAZ) [Time frame: at 0, 1, 2, 3, 6 and 12 months of enrollment]
  • Gesell Developmental Scale Test [Time frame: at 0, 6, and 12 months of enrollment]
  • Infants - Junior High School Students Social Competence Test (S-M test) [Time frame: at 0, 6, and 12 months of enrollment]
  • Pediatric Quality of Life Inventory (PedsQL) [Time frame: at 0, 6, and 12 months of enrollment]
  • the Chinese version of the World Health Organization Quality of Life-BREF (WHOQOL-BREF) [Time frame: at 0, 6 and 12 months of enrollment]
  • Gut Health Questionnaire [Time frame: at 0, 1,3, 6, and 12 months of enrollment]
  • Infectious Diseases Related Questionnaire [Time frame: at 0, 1,3, 6, and 12 months of enrollment]
  • Blood Routine Test [Time frame: at 0, 6 and 12 months of enrollment]
  • Liver Function Test [Time frame: at 0, 6 and 12 months of enrollment]

Eligibility criteria

Inclusion criteria

  • Aged 1-3 years
  • BMI for Age Z-score<-2
  • Height-for-age z score<-2
  • Total daily energy intake<75% of recommended nutrient intake
  • The child's guardian is willing to participate in this study and sign an informed consent form.

Exclusion criteria

  • Chronic or severe infectious disease (e.g., chronic hepatitis, HIV or tuberculosis infection)
  • Certain congenital or genetic diseases affecting physical growth and development (congenital heart disease, Down's syndrome, infantile anorexia nervosa, etc.), malignancies and use of drugs (diuretics, appetite stimulants, steroids and growth hormones, etc.)
  • Severe gastrointestinal disorders (e.g., celiac disease, short bowel syndrome, inflammatory bowel disease, etc.)
  • Acute and chronic respiratory/digestive tract infections within 2 weeks prior to enrollment
  • Allergy or contraindication to any of the ingredients in the high-energy total nutrition formula used in this study
  • Have used high-energy enteral nutrition preparations for the last 3 months

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

China · 13 centers
  • Anhui Provincial Children's Hospital — Hefei
  • Children's Hospital of The Capital Institute of Pediatrics — Beijing
  • The First Hospital of Jilin University — Jilin City
  • Growth, Development and Mental health of Children and Adolescence Center — Chongqing
  • Guangzhou Women and Children's Medical Center — Guangzhou
  • Guiyang Maternity and Child Health Care Hospital — Guiyang
  • Hunan Children's Hospital — Changsha
  • Nanjing Maternity and Child Health Care Hospital — Nanjing
  • … and 5 more centers

Publications

  • Hemming K, Taljaard M, McKenzie JE, Hooper R, Copas A, Thompson JA, Dixon-Woods M, Aldcroft A, Doussau A, Grayling M, Kristunas C, Goldstein CE, Campbell MK, Girling A, Eldridge S, Campbell MJ, Lilford RJ, Weijer C, Forbes AB, Grimshaw JM. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 2018 Nov 9;363:k1614. doi: PMID 30413417

Identifiers

NCT: NCT05911893 · EHCONSGDMC

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗